Rockville biotech OpGen shrinks headcount, scales down U.S. operations

OpGen Inc. (NASDAQ: OPGN) is the latest local biotech to overhaul its business — slashing its headcount, executive pay and functions — to conserve cash and try to stay afloat. The company, which develops rapid diagnostics for infectious diseases, announced this week it will lay off the majority of its staff and scale down its U.S. operations in Rockville.